Target
TGF-beta receptor type-1
Ligand
BDBM282792
Substrate
n/a
Meas. Tech.
ChEMBL_1838901 (CHEMBL4339034)
IC50
80±n/a nM
Citation
 Velaparthi, UDarne, CPWarrier, JLiu, PRahaman, HAugustine-Rauch, KParrish, KYang, ZSwanson, JBrown, JDhar, GAnandam, AHolenarsipur, VKPalanisamy, KWautlet, BSFereshteh, MPLippy, JTebben, AJSheriff, SRuzanov, MYan, CGupta, AGupta, AKVetrichelvan, MMathur, AGelman, MSingh, RKinsella, TMurtaza, AFargnoli, JVite, GBorzilleri, RM Discovery of BMS-986260, a Potent, Selective, and Orally Bioavailable TGF?R1 Inhibitor as an Immuno-oncology Agent. ACS Med Chem Lett 11:172-178 (2020) [PubMed]  Article
Target
Name:
TGF-beta receptor type-1
Synonyms:
ALK-5 | ALK5 | Activin A receptor type II-like protein kinase of 53kD | Activin receptor-like kinase 5 | SKR4 | Serine/threonine-protein kinase receptor R4 | TGF-beta receptor type I | TGF-beta type I receptor | TGFBR1 | TGFR-1 | TGFR1_HUMAN | TbetaR-I | Transforming growth factor-beta receptor type I
Type:
enzyme
Mol. Mass.:
55968.24
Organism:
Homo sapiens (Human)
Description:
P36897
Residue:
503
Sequence:
MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM
  
Inhibitor
Name:
BDBM282792
Synonyms:
6-(1-(2,2-difluoroethyl)-4-(4-fluorophenyl)-1H- imidazol-5-yl)imidazo[1,2-b]pyridazine-3-carbonitrile | US10287295, Example 1' | US11352360, Example 1' | US9884868, Example 1'
Type:
Small organic molecule
Emp. Form.:
C18H11F3N6
Mol. Mass.:
368.3153
SMILES:
FC(F)Cn1cnc(c1-c1ccc2ncc(C#N)n2n1)-c1ccc(F)cc1
Structure:
Search PDB for entries with ligand similarity: